Diana Farmer
Institution Name:
University of California, Davis
Total Awards:
2
Award Value:
$7,848,223
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Preclinical Development Awards | University of California, Davis | Placental Stem Cells for the In Utero Treatment of Spina Bifida | $2,182,146 |
| Late Stage Preclinical Projects | University of California, Davis | Placental Mesenchymal Stem Cell Augmentation of Fetal Myelomeningocele Repair | $5,666,077 |
Total: $7,848,223.00 |
Publications
- Placenta 2017 Effect of 2-octylcyanoacrylate on placenta derived mesenchymal stromal cells on extracellular matrix. (PubMed: 28465002)
- Cytotherapy 2017 Manufacture and preparation of human placenta-derived mesenchymal stromal cells for local tissue delivery. (PubMed: 28438482)
- J Pediatr Surg 2017 Placental mesenchymal stromal cells seeded on clinical grade extracellular matrix improve ambulation in ovine myelomeningocele. (PubMed: 29122293)
- J Pediatr Surg 2017 Fetal surgical repair with placenta-derived mesenchymal stromal cell engineered patch in a rodent model of myelomeningocele. (PubMed: 29096888)
- Placenta 2017 Potential clinical applications of placental stem cells for use in fetal therapy of birth defects. (PubMed: 28651900)
- J Pediatr Surg 2018 High density placental mesenchymal stromal cells provide neuronal preservation and improve motor function following in utero treatment of ovine myelomeningocele. (PubMed: 30529115)
- FASEB J 2019 Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes. (PubMed: 30753093)
- Fetal Diagn Ther 2019 Spinal Angulation: A Limitation of the Fetal Lamb Model of Myelomeningocele. (PubMed: 30970373)
- J Pediatr Surg 2019 In Utero Treatment of Myelomeningocele with Placental Mesenchymal Stromal Cells - Selection of an Optimal Cell Line in Preparation for Clinical Trials. (PubMed: 31672407)